Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye
Robert Sambursky Coastal Eye Institute, Cornea and Comprehensive Ophthalmology, Bradenton, FL, USA Background: The presence of clinically significant inflammation has been confirmed in the tears of 40%–65% of patients with symptoms of dry eye. Ocular surface inflammation may lead to tear...
Main Author: | Sambursky R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-11-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/presence-or-absence-of-ocular-surface-inflammation-directs-clinical-an-peer-reviewed-article-OPTH |
Similar Items
-
Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation
by: Ritika Mullick, et al.
Published: (2021-01-01) -
Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
by: Deveney T, et al.
Published: (2018-03-01) -
Comparison of matrix metallopeptidase-9 expression following cyclosporine and diquafosol treatment in dry eye
by: Ha Rim So, et al.
Published: (2023-12-01) -
The effect of acute exercise on environmentally induced symptoms of dry eye
by: Daniel J. Peart, et al.
Published: (2020-01-01) -
Clinical observation of cyclosporine eye drops with artificial tears for dry eyes
by: Xue-Bing Yang, et al.
Published: (2016-05-01)